These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9865298)

  • 1. Therapeutic drug monitoring of tacrolimus in kidney transplantation: 9-month follow-up.
    Brunet M; Torregrosa JV; Oppenheimer F; Corbella J
    Transplant Proc; 1998 Dec; 30(8):4068-9. PubMed ID: 9865298
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
    Yu L; Wang Y; Fu SJ; Cheng XJ
    Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
    [No Abstract]   [Full Text] [Related]  

  • 3. Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation.
    Uchida K; Tominaga Y; Haba T; Katayama T; Matsuoka S; Sato T; Goto N; Takeda A; Morozumi K; Takagi H
    Transplant Proc; 2002 Aug; 34(5):1736-7. PubMed ID: 12176556
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group.
    Undre NA; Schäfer A
    Transplant Proc; 1998 Jun; 30(4):1261-3. PubMed ID: 9636512
    [No Abstract]   [Full Text] [Related]  

  • 5. Monotherapy with tacrolimus and corticosteroid withdrawal.
    Lauzurica R; Ara J; Fernández P; Bayés B; Bonet J; Romero R
    Transplant Proc; 2002 Feb; 34(1):120-1. PubMed ID: 11959217
    [No Abstract]   [Full Text] [Related]  

  • 6. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
    Dudley CR;
    Transplant Proc; 2001; 33(1-2):1034-5. PubMed ID: 11267179
    [No Abstract]   [Full Text] [Related]  

  • 7. The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients.
    Pisitkun T; Eiam-Ong S; Chusil S; Praditpornsilpa K; Pansin P; Tungsanga K
    Transplant Proc; 2002 Dec; 34(8):3173-5. PubMed ID: 12493410
    [No Abstract]   [Full Text] [Related]  

  • 8. A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.
    Shapiro R; Scantlebury VP; Jordan ML; Vivas CA; Jain A; Hakala TR; McCauley J; Johnston J; Randhawa P; Fedorek S; Gray E; Chesky A; Dvorchik I; Donaldson J; Fung JJ; Starzl TE
    Transplant Proc; 2002 Aug; 34(5):1651-2. PubMed ID: 12176521
    [No Abstract]   [Full Text] [Related]  

  • 9. Defining the initial doses of sirolimus and tacrolimus in the period immediately after renal transplantation.
    Jiménez O; Campistol JM; Vidal E; Faura A; Oppenheimer F; Corbella J; Brunet M
    Transplant Proc; 2003 Aug; 35(5):1686-8. PubMed ID: 12962758
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral vs intravenous tacrolimus-based induction therapy in renal transplantation.
    Tojimbara T; Kimikawa M; Nakajima I; Sato S; Nakamura M; Ishida H; Tanabe K; Koyama I; Utsumi K; Sannomiya A; Tsuji K; Fuchinoue S; Agishi T
    Transplant Proc; 1999 Nov; 31(7):2763-4. PubMed ID: 10578282
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term outcome of tacrolimus rescue therapy in late rejection after renal transplantation.
    Budde K; Smettan S; Fritsche L; Waiser J; Giessing M; Kunz R; Türk I; Bauer S; Mai I; Neumayer HH
    Transplant Proc; 1998 Aug; 30(5):1780-1. PubMed ID: 9723280
    [No Abstract]   [Full Text] [Related]  

  • 12. Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients.
    Sato S; Fuchinoue S; Tojimbara T; Fujita S; Nakajima I; Agishi T; Hayashi T; Teramura Y; Fujita E; Iwasaki K
    Transplant Proc; 1998 Jun; 30(4):1274-5. PubMed ID: 9636517
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients.
    Manzanares C; Moreno M; Castellanos F; Cubas A; Herrero JC; Morales-Ruiz E; Segura J; Andres A; Morales JM
    Transplant Proc; 1998 Jun; 30(4):1264-5. PubMed ID: 9636513
    [No Abstract]   [Full Text] [Related]  

  • 14. Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis.
    Busque S; Demers P; St-Louis G; Boily JG; Tousignant J; Lemieux F; Smeesters C; Corman J; Daloze P
    Transplant Proc; 1998 Jun; 30(4):1247-8. PubMed ID: 9636507
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation.
    Kliem V; Radermacher J; Hiss M; Pethig M; Burg M; Brunkhorst R
    Transplant Proc; 1999 Nov; 31(7A):37S-40S. PubMed ID: 10576041
    [No Abstract]   [Full Text] [Related]  

  • 16. Alterations in calcineurin phosphatase activity in tacrolimus-treated renal transplant patients.
    Koefoed-Nielsen PB; Jørgensen KA
    Transplant Proc; 2002 Aug; 34(5):1743-4. PubMed ID: 12176559
    [No Abstract]   [Full Text] [Related]  

  • 17. Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity.
    Diekmann F; Waiser J; Fritsche L; Dragun D; Neumayer HH; Budde K
    Transplant Proc; 2001; 33(7-8):3234-5. PubMed ID: 11750386
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients.
    Capone D; Gentile A; Vajro P; Stanziale P; Imperatore P; De Silva C; Pellegrino T; Basile V
    J Chemother; 1998 Apr; 10(2):176-8. PubMed ID: 9603651
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil.
    Sola E; Alférez MJ; Cabello M; Burgos D; González Molina M
    Transplant Proc; 2002 Aug; 34(5):1689-90. PubMed ID: 12176537
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective study of a tacrolimus-based quadruple immunosuppressive regimen: evaluation of safety and efficacy.
    Lladó L; Figueras J; Ramos E; Baliellas C; Torras J; Rafecas A; Fabregat J; Lama C; Ibañez L; Jaurrieta E
    Transplant Proc; 2002 Aug; 34(5):1526-8. PubMed ID: 12176468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.